These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 35043754)

  • 1. Identification of natural products against enoyl-acyl-carrier-protein reductase in malaria via combined pharmacophore modeling, molecular docking and simulations studies.
    Manhas A; Ghosh A; Verma Y; Das T; Jha PC
    J Biomol Struct Dyn; 2023 Mar; 41(5):2002-2015. PubMed ID: 35043754
    [No Abstract]   [Full Text] [Related]  

  • 2. Identification of PfENR inhibitors: A hybrid structure-based approach in conjunction with molecular dynamics simulations.
    Manhas A; Patel A; Lone MY; Jha PK; Jha PC
    J Cell Biochem; 2018 Nov; 119(10):8490-8500. PubMed ID: 30105881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-Based Design and Pharmacophore-Based Virtual Screening of Combinatorial Library of Triclosan Analogues Active against Enoyl-Acyl Carrier Protein Reductase of
    Bieri C; Esmel A; Keita M; Owono LCO; Dali B; Megnassan E; Miertus S; Frecer V
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of the natural compound inhibitors against
    Manhas A; Kumar S; Jha PC
    J Biomol Struct Dyn; 2022 Jan; 40(1):31-43. PubMed ID: 32794426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel antiplasmodial compound: integration of
    Costa Júnior DB; Araújo JSC; Oliveira LM; Neri FSM; Moreira POL; Taranto AG; Fonseca AL; Varotti FP; Leite FHA
    J Biomol Struct Dyn; 2022 Sep; 40(14):6295-6307. PubMed ID: 33554762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A profound computational study to prioritize the natural compound inhibitors against the
    Manhas A; Dubey S; Jha PC
    J Biomol Struct Dyn; 2020 Jun; 38(9):2704-2716. PubMed ID: 31304874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Celastrol inhibits Plasmodium falciparum enoyl-acyl carrier protein reductase.
    Tallorin LC; Durrant JD; Nguyen QG; McCammon JA; Burkart MD
    Bioorg Med Chem; 2014 Nov; 22(21):6053-6061. PubMed ID: 25284249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multicomplex-based pharmacophore modeling in conjunction with multi-target docking and molecular dynamics simulations for the identification of
    Manhas A; Lone MY; Jha PC
    J Biomol Struct Dyn; 2019 Oct; 37(16):4181-4199. PubMed ID: 30648473
    [No Abstract]   [Full Text] [Related]  

  • 9. Combined 3D-QSAR and Molecular Docking Study for Identification of Diverse Natural Products as Potent Pf ENR Inhibitors.
    Wadhwa P; Saha D; Sharma A
    Curr Comput Aided Drug Des; 2015; 11(3):245-57. PubMed ID: 26517356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prioritization of active antimalarials using structural interaction profile of Plasmodium falciparum enoyl-acyl carrier protein reductase (PfENR)-triclosan derivatives.
    Kumar SP; George LB; Jasrai YT; Pandya HA
    SAR QSAR Environ Res; 2015; 26(1):61-77. PubMed ID: 25567142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 3D-QSAR studies on triclosan derivatives as Plasmodium falciparum enoyl acyl carrier reductase inhibitors.
    Shah P; Siddiqi MI
    SAR QSAR Environ Res; 2010 Jul; 21(5-6):527-45. PubMed ID: 20818586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Virtually Designed Triclosan-Based Inhibitors of Enoyl-Acyl Carrier Protein Reductase of Mycobacterium tuberculosis and of Plasmodium falciparum.
    Owono Owono LC; Ntie-Kang F; Keita M; Megnassan E; Frecer V; Miertus S
    Mol Inform; 2015 May; 34(5):292-307. PubMed ID: 27490275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular modeling studies, synthesis, and biological evaluation of Plasmodium falciparum enoyl-acyl carrier protein reductase (PfENR) inhibitors.
    Morde VA; Shaikh MS; Pissurlenkar RR; Coutinho EC
    Mol Divers; 2009 Nov; 13(4):501-17. PubMed ID: 19347595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In silico screening for Plasmodium falciparum enoyl-ACP reductase inhibitors.
    Lindert S; Tallorin L; Nguyen QG; Burkart MD; McCammon JA
    J Comput Aided Mol Des; 2015 Jan; 29(1):79-87. PubMed ID: 25344312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of novel inhibitors targeting enoyl-acyl carrier protein reductase in Plasmodium falciparum by structure-based virtual screening.
    Nicola G; Smith CA; Lucumi E; Kuo MR; Karagyozov L; Fidock DA; Sacchettini JC; Abagyan R
    Biochem Biophys Res Commun; 2007 Jul; 358(3):686-91. PubMed ID: 17509532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of Mycobacterium tuberculosis enoyl-acyl carrier protein reductase inhibitors: A combined in-silico and in-vitro analysis.
    Lone MY; Athar M; Gupta VK; Jha PC
    J Mol Graph Model; 2017 Sep; 76():172-180. PubMed ID: 28734205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of natural compound inhibitors against PfDXR: A hybrid structure-based molecular modeling approach and molecular dynamics simulation studies.
    Manhas A; Patel D; Lone MY; Jha PC
    J Cell Biochem; 2019 Sep; 120(9):14531-14543. PubMed ID: 30994966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multicomplex-based pharmacophore modeling coupled with molecular dynamics simulations: An efficient strategy for the identification of novel inhibitors of PfDHODH.
    Manhas A; Lone MY; Jha PC
    J Mol Graph Model; 2017 Aug; 75():413-423. PubMed ID: 28651831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benzothiophene carboxamide derivatives as inhibitors of Plasmodium falciparum enoyl-ACP reductase.
    Banerjee T; Sharma SK; Kapoor N; Dwivedi V; Surolia N; Surolia A
    IUBMB Life; 2011 Dec; 63(12):1101-10. PubMed ID: 22006792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of novel antiplasmodial compound by hierarquical virtual screening and
    Costa Júnior DB; Araújo JSC; de Mattos Oliveira L; Neri FSM; Moreira POL; Taranto AG; Fonseca AL; de Pilla Varotti F; Leite FHA
    J Biomol Struct Dyn; 2021 Jun; 39(9):3378-3386. PubMed ID: 32364060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.